Journal Watch · Science Advances · 2026

Synchronous wearable ultrasound for early detection of coronary and carotid artery comorbidity.

This integrated approach constitutes a promising framework for supporting the proactive assessment of coronary-carotid comorbidity.

Lin S, Xu H, Li Y et al.Science Advances3 min readPharma relevance 75/100

DOI: 10.1126/sciadv.aed2114PMID: 42319947Study type: clinical study

TL;DR

This integrated approach constitutes a promising framework for supporting the proactive assessment of coronary-carotid comorbidity.

Key findings

  • By evaluating the correlation of these metrics between modeling and measurements, we showed the feasibility of differentiating among healthy participants and patients with CAD, CHD, or CAD-CHD comorbidity.
  • This integrated approach constitutes a promising framework for supporting the proactive assessment of coronary-carotid comorbidity.

What they did

In this work, we developed a wearable ultrasound system that enables synchronous monitoring of cardiac and carotid dynamics for comorbidity assessment. The system combines dual wearable ultrasound patches, a synchronous imaging strategy, artificial intelligence-based image processing algorithms, and human circuitry models to automatically extract and analyze key cardiac-carotid metrics, such as heart rate, pulse rate, cardiac volume, cardiac output, and carotid blood pressure.

Full abstract (original)

Background: Coronary heart disease (CHD) and carotid artery disease (CAD) often co-occur. However, conventional diagnosis typically involves separate, site-by-site examinations after symptoms appear, leading to delayed intervention.

What they did: In this work, we developed a wearable ultrasound system that enables synchronous monitoring of cardiac and carotid dynamics for comorbidity assessment. The system combines dual wearable ultrasound patches, a synchronous imaging strategy, artificial intelligence-based image processing algorithms, and human circuitry models to automatically extract and analyze key cardiac-carotid metrics, such as heart rate, pulse rate, cardiac volume, cardiac output, and carotid blood pressure.

Results & conclusions: By evaluating the correlation of these metrics between modeling and measurements, we showed the feasibility of differentiating among healthy participants and patients with CAD, CHD, or CAD-CHD comorbidity. This integrated approach constitutes a promising framework for supporting the proactive assessment of coronary-carotid comorbidity.

Abstract © the authors / Science Advances (2026). Reproduced here for discussion and indexing, with attribution. Read the original at https://doi.org/10.1126/sciadv.aed2114 · PubMed 42319947.

Why it matters for pharma & biotech

  • Directly relevant to teams in AI in drug discovery / diagnostics — the abstract reports new data in that space, so competitive and pipeline teams should read the full text.
  • Because it reports human data, it can inform indication, endpoint and comparator decisions faster than preclinical work.
  • For searchers: the full abstract is reproduced below, so you can judge relevance before opening the publisher page.

Modalities & themes detected: AI in drug discovery / diagnostics

Limitations & what to check in the full text

  • This brief is based on the published abstract only. Effect sizes, subgroup results and safety detail in the full text may qualify the headline findings.
  • The abstract reports its conclusions qualitatively, without headline effect sizes — read the full text before citing a magnitude.

Frequently asked questions

What did this Science Advances study find?

This integrated approach constitutes a promising framework for supporting the proactive assessment of coronary-carotid comorbidity.

What type of study is this?

It is a clinical study, published in Science Advances in 2026. In this work, we developed a wearable ultrasound system that enables synchronous monitoring of cardiac and carotid dynamics for comorbidity assessment.

Where can I read the original paper?

The original is at the publisher via DOI 10.1126/sciadv.aed2114. PubMed ID: 42319947. BioStudioAI reproduces the abstract for discussion and links to the source.

How to cite the original: Lin S, Xu H, Li Y et al.. Synchronous wearable ultrasound for early detection of coronary and carotid artery comorbidity.. Science Advances (2026). DOI: 10.1126/sciadv.aed2114.
This brief: BioStudioAI Journal Watch, 29 October 2026. https://biostudioai.com/blog/papers/synchronous-wearable-ultrasound-for-early-detection-of-coronary-and-caro-ed2114/

Reading papers is step one. Analysing the data is the work.

BioStudioAI turns raw lab files into QC'd results, statistics, figures, reports and slides — hosted on your servers, every number computed, nothing typed.

Open BioStudioAI More guides